Amolyt Pharma
Trending Articles
Related Content
Research & Development
Amolyt Pharma named "Biotech Company of the Year" at the LSX European Lifestars Awards
Amolyt, a global company specialised in developing therapeutic peptides for rare endocrine and related diseases, has been awarded the "Biotech Company of the Year 2023" at the annual LSX, European Lifestars Awards Ceremony, held on 13 November in London, UK